- Pacira Pharmaceuticals, Inc. (“Pacira”) (NASDAQ: PCRX) and MyoScience, Inc. (“MyoScience”), a privately held medical technology company, today announced the signing of a definitive agreement for the acquisition of MyoScience by Pacira.

The goal of the Opioid Risk Reduction Initiative--an educational effort focused on responsible use and increased awareness of opioid alternatives--is to improve the cancer patient experience through expanded pain management options.